The US Food and Drug Administration (FDA) said on Friday that it will quickly work toward finalization and issuance of an emergency use authorization for the Pfizer/BioNTech coronavirus disease 2019 (Covid-19) vaccine.
The announcement came a day after an advisory panel, voting 17-4, recommended to the FDA that the company’s Covid-19 vaccine be granted the emergency use authority.
“Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech Covid-19 vaccine, the US Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization,” FDA Commissioner Stephen M. Hahn and Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
“The agency has also notified the US Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution,” they added.
The Covid-19 vaccine of Pfizer-BioNTech Covid-19 is currently leading other candidate vaccines in the US and United Kingdom where it was already authorized for use. SOVEREIGNPH